FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Posts Regulatory Science Tools for Devices

FDA posts a catalog of regulatory science tools to help sponsors assess new medical devices.

Medical Devices

EUA Given to Yales Saliva Covid Test

FDA issues an emergency use authorization to Yale School of Public Health for its SalivaDirect Covid-19 diagnostic test.

Federal Register

Info Collection on Rapid Surveys

Federal Register notice: FDA sends to OMB an information collection extension for Food and Drug Administration Rapid Response Surveys (OMB Control Num...

Human Drugs

Trump Holds Meeting on Another Unproven Covid-19 Therapy

President Trump turns some attention to an extract from the oleander plant as an unproven cure for Covid-19, leading to speculation that he may be qui...

Federal Register

ClinicalTrials.com Civil Money Penalties Guide

Federal Register notice: FDA issues a final guidance on ClinicalTrials.com civil money penalties.

Medical Devices

FDA False Results Alert on Thermo Fisher Covid Tests

FDA alerts clinical laboratory staff and health care providers about a risk of false results with Thermo Fisher Scientific TaqPath Covid-19 Combo Kit.

Human Drugs

Myovant Sciences NDA for Uterine Fibroid Drug

FDA accepts for review a Myovant Sciences NDA for its once-daily, oral relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindr...

Human Drugs

Genentech Optic Nerve Rare Disease Drug Approved

FDA approves a Genentech BLA for Enspryng (satralizumab-mwge) for treating neuromyelitis optica spectrum disorder in adults with a particular antibody...

Federal Register

Bone Growth Stimulator Proposed Reclassification

Federal Register notice: FDA proposes to reclassify non-invasive bone growth stimulators from postamendments Class 3 devices into Class 2.

Biologics

Untitled Letter Objects to Web Claims by Cell Therapy Firm

CBERs Office of Compliance and Biologics Quality sends East West Health Solutions (Lake City, UT) an untitled letter based on a review of claims about...